METARAMINOL
Colorectal Cancer (Diagnosis)
The Nethersole School of NursingSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Colorectal Cancer (Diagnosis) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Abt-301 Anbogen Therapeutics, Inc. | Phase 1/2 | CC |
S-Adenosyl-L-Methionine Jun Gong, MD | Phase 1 | CC |
Midodrine The Nethersole School of Nursing | N/A | D |
Plavix The Nethersole School of Nursing | N/A | D |
NORADRENALINE TARTRATE IMPURITY C The Nethersole School of Nursing | N/A | D |
Same molecule, other indications
METARAMINOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →